Lunenfeld-Tanenbaum Research Institute

Research Resources  |   RTC  |   sciHigh  |   HR & CV Bank  |   Finance  |   Grants  |   Technology Transfer  |   Administrative Assistants  |   Biobar  |   Safety  |  
Research Centre for
Women's and Infants' Health



Collaboration and interaction among scientists and clinicians are important sources of strength of the RCWIH, and foster timely and effective translation of research into improved clinical care. Examples of collaboration include:

A multi-centre international trial to determine the effectiveness of Multiple Courses of Antenatal Corticosteroids (the MACS trial) on neonatal outcomes following preterm delivery. Dr. Kellie Murphy, the lead investigator, is collaborating with other RCWIH members and with investigators from 80 other institutions in 20 countries worldwide. This study’s outcome will directly impact the clinical care of women with threatened preterm delivery, a condition that affects up to 10% of pregnancies in Canada

  • Drs. Whittle, Lye, Adamson, Bocking, Challis and Kingdom are jointly initiating clinical studies of a novel treatment to prevent preterm birth.

  • Drs. Rossant, Adamson and Quaggin collaborate on research generating new mouse models of human disease.

  • Investigators within the RCWIH jointly supervise students and fellows and belong to several strategic training initiatives.

Basic scientists in the Lunenfeld’s RCWIH have close collaborations with clinician scientists within the Lunenfeld and with clinicians within the Department of Obstetrics and Gynecology at Mount Sinai Hospital . In addition, the members of RCWIH have developed strong research links with other related groups within the city and within Canada , as well as internationally in Australia , Germany , United Kingdom , and U.S.A. Collaborative research interests include ovarian cancer, osteoporosis, artificial reproductive technologies, preterm birth, preeclampsia, intrauterine growth restriction, and fetal therapy.



/ Research / Collaborations